Axing Restasis Patents Would Stifle Innovation, PhRMA Warns
Law360, New York (January 31, 2018, 8:40 PM EST) — The Pharmaceutical Research and Manufacturers of America on Wednesday warned the Federal Circuit that allowing a district court to invalidate four patents tied to the dry-eye medication Restasis will block innovation in the pharmaceutical …